Post by
tylerreddick on Oct 11, 2024 5:25pm
Bottom line
With GPM hitting the market in a matter of months, SBM will get that financing partner. There is a LOT of private equity cash crying for an opportunity to get in on any kind of bottom floor invetsment such as Sirona.
Yes, there will be dilution. But the simple fact is that once we have the money to put GPM in the hands of eager consumers around the world, the company will have the momentum to continue developing other products. And maybe we can tell Abbvie to take a hike, and follow a similar path with TFC-1067, putting it on the market ourselvs.
Once we get the news release announcing the financing, these low share prices will be a thing of the past. And that could come any day.